ストックスクリーナーアプリを入手
65.12
4.35%
-2.96
アフターアワーズ：
65.10
-0.02
-0.03%
前日終値:
$68.08
開ける：
$68.15
24時間の取引高:
3.50M
Relative Volume:
0.75
時価総額：
$25.54B
収益：
$4.30B
当期純損益:
$571.50M
株価収益率:
45.59
EPS:
1.4285
ネットキャッシュフロー:
$570.80M
1週間 パフォーマンス:
-2.88%
1か月 パフォーマンス:
-14.32%
6か月 パフォーマンス:
-3.24%
1年 パフォーマンス:
-6.38%
1日の値動き範囲:
$65.03
$68.50
1週間の範囲:
$64.90
$69.00
52週間の値動き範囲:
$57.52
$93.25
Dexcom Inc Stock (DXCM) Company Profile
DXCM を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
DXCM
Dexcom Inc
|
65.12 | 26.70B | 4.30B | 571.50M | 570.80M | 1.4285 |
|
ABT
Abbott Laboratories
|
132.57 | 232.02B | 43.11B | 13.94B | 6.78B | 7.9963 |
|
BSX
Boston Scientific Corp
|
95.41 | 144.14B | 18.49B | 2.50B | 3.49B | 1.6801 |
|
SYK
Stryker Corp
|
364.60 | 141.53B | 23.82B | 2.92B | 4.02B | 7.5574 |
|
MDT
Medtronic Plc
|
95.45 | 123.78B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
73.94 | 44.14B | 5.69B | 1.41B | 577.90M | 6.9828 |
Dexcom Inc Stock (DXCM) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-09-08 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2025-08-21 | 開始されました | Argus | Buy |
| 2025-06-16 | 開始されました | Truist | Buy |
| 2025-05-30 | 開始されました | Goldman | Buy |
| 2025-04-10 | 開始されました | Mizuho | Outperform |
| 2025-02-03 | アップグレード | Redburn Atlantic | Neutral → Buy |
| 2025-01-16 | アップグレード | Robert W. Baird | Neutral → Outperform |
| 2024-07-26 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2024-07-26 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2024-05-30 | 開始されました | Redburn Atlantic | Neutral |
| 2024-03-12 | 開始されました | RBC Capital Mkts | Outperform |
| 2023-05-30 | 再開されました | Morgan Stanley | Equal-Weight |
| 2023-04-17 | アップグレード | Raymond James | Outperform → Strong Buy |
| 2023-03-29 | 開始されました | UBS | Buy |
| 2023-01-26 | 開始されました | Wolfe Research | Outperform |
| 2022-10-18 | 開始されました | Barclays | Equal Weight |
| 2022-10-12 | 開始されました | Jefferies | Buy |
| 2022-07-15 | 開始されました | Bernstein | Outperform |
| 2022-03-02 | 再開されました | BofA Securities | Buy |
| 2022-02-03 | アップグレード | BTIG Research | Neutral → Buy |
| 2022-01-19 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2022-01-07 | アップグレード | Guggenheim | Neutral → Buy |
| 2021-10-18 | ダウングレード | Guggenheim | Buy → Neutral |
| 2021-07-21 | 再開されました | Cowen | Outperform |
| 2021-05-28 | アップグレード | Wells Fargo | Underweight → Equal Weight |
| 2021-05-25 | 開始されました | Barclays | Overweight |
| 2021-04-15 | 開始されました | Atlantic Equities | Overweight |
| 2021-01-06 | アップグレード | UBS | Neutral → Buy |
| 2020-10-02 | ダウングレード | Wells Fargo | Equal Weight → Underweight |
| 2020-05-27 | 繰り返されました | Piper Sandler | Overweight |
| 2020-05-14 | 開始されました | Wells Fargo | Equal Weight |
| 2020-03-05 | 開始されました | Citigroup | Buy |
| 2019-11-07 | 繰り返されました | Canaccord Genuity | Buy |
| 2019-11-07 | アップグレード | Guggenheim | Neutral → Buy |
| 2019-10-23 | 開始されました | Stifel | Buy |
| 2018-11-28 | 開始されました | UBS | Neutral |
| 2018-10-19 | アップグレード | Goldman | Sell → Neutral |
| 2018-09-12 | アップグレード | Northland Capital | Under Perform → Market Perform |
| 2018-08-02 | 繰り返されました | Canaccord Genuity | Buy |
| 2018-07-02 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2018-06-08 | アップグレード | JP Morgan | Neutral → Overweight |
| 2018-05-11 | 開始されました | BofA/Merrill | Buy |
| 2018-05-03 | 繰り返されました | Canaccord Genuity | Buy |
| 2018-04-04 | 開始されました | Goldman | Sell |
| 2018-04-04 | 開始されました | Guggenheim | Neutral |
| 2018-03-23 | アップグレード | Robert W. Baird | Neutral → Outperform |
| 2018-01-04 | ダウングレード | Northland Capital | Market Perform → Under Perform |
| 2017-09-28 | 繰り返されました | Wedbush | Outperform |
すべてを表示
Dexcom Inc (DXCM) 最新ニュース
DexCom, Masimo, Integer Holdings, The Pennant Group, and Organon Stocks Trade Down, What You Need To Know - TradingView
Will DexCom Inc. benefit from macro trendsSell Signal & Technical Analysis for Trade Confirmation - newser.com
Can DexCom Inc. (DC4) stock sustain double digit ROEWeekly Stock Summary & Daily Volume Surge Signals - newser.com
Real time scanner hits for DexCom Inc. explained2025 Volume Leaders & Daily Risk Controlled Trade Plans - newser.com
What MACD trends signal for DexCom Inc. (DC4) stockEarnings Summary Report & Community Driven Trade Alerts - newser.com
Blair William & Co. IL Lowers Position in DexCom, Inc. $DXCM - MarketBeat
Why DexCom Inc. stock remains on watchlistsPortfolio Risk Report & Entry Point Confirmation Alerts - newser.com
DexCom Inc. stock trend forecastJuly 2025 Catalysts & Capital Efficiency Focused Strategies - newser.com
DexCom (NASDAQ:DXCM) Receives Hold (C-) Rating from Weiss Ratings - MarketBeat
Is it too late to sell DexCom Inc.2025 Investor Takeaways & Target Return Focused Picks - newser.com
Is DexCom Inc. (DC4) stock resilient in recession scenarios2025 Investor Takeaways & Reliable Volume Spike Alerts - newser.com
Can DexCom Inc. stock deliver sustainable ROEWeekly Stock Report & Low Drawdown Investment Strategies - newser.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of DexCom, Inc.DXCM - PR Newswire
DexCom Inc Stock Analysis and ForecastIPO Market Watch & Exceptional Capital Trading - earlytimes.in
Shell Asset Management Co. Buys 5,138 Shares of DexCom, Inc. $DXCM - MarketBeat
DexCom, Inc. $DXCM Stake Raised by DAVENPORT & Co LLC - MarketBeat
Janney Montgomery Scott LLC Trims Stake in DexCom, Inc. $DXCM - MarketBeat
William Blair Maintains Bullish Stance on DexCom (DXCM) Stock - Yahoo
Citigroup Issues Pessimistic Forecast for DexCom (NASDAQ:DXCM) Stock Price - MarketBeat
DexCom (DXCM): Citigroup Lowers Price Target, Maintains "Buy" Ra - GuruFocus
What analysts say about DexCom Inc DC4 stockSector Performance Drivers & Diversify Intelligently to Avoid Big Hits - earlytimes.in
Applying big data sentiment scoring on DexCom Inc.Trend Reversal & Entry and Exit Point Strategies - newser.com
Comprehensive Financial Consultants Institutional Inc. Grows Position in DexCom, Inc. $DXCM - MarketBeat
Can DexCom Inc. (DC4) stock deliver consistent EPS growthWeekly Trend Summary & Low Risk Entry Point Guides - newser.com
DexCom May Be The Most Underrated Growth Story In Healthcare (NASDAQ:DXCM) - Seeking Alpha
What dividend safety rating applies to DexCom Inc. (DC4) stockEarnings Overview Report & AI Forecasted Entry and Exit Points - newser.com
DexCom, Inc. $DXCM Shares Purchased by Sendero Wealth Management LLC - MarketBeat
Combining price and volume data for DexCom Inc.July 2025 Fed Impact & Daily Growth Stock Tips - newser.com
DexCom (DXCM): Valuation Insights as G7 Reliability Improves and Reimbursement Expands - Sahm
DexCom, Inc. Reports Second Quarter 2017 Financial Results - ADVFN
Published on: 2025-10-05 05:15:42 - newser.com
Is DexCom Inc. stock entering bullish territoryWeekly Loss Report & Free Weekly Chart Analysis and Trade Guides - newser.com
Mirae Asset Global Investments Co. Ltd. Has $16.65 Million Stock Position in DexCom, Inc. $DXCM - MarketBeat
Robeco Institutional Asset Management B.V. Sells 31,727 Shares of DexCom, Inc. $DXCM - MarketBeat
Why Analysts See DexCom’s Outlook Shifting Amid New Leadership and Changing Growth Drivers - Yahoo Finance
Franklin Street Advisors Inc. NC Makes New $686,000 Investment in DexCom, Inc. $DXCM - MarketBeat
DexCom Stock Price, Quotes and Forecasts | NASDAQ:DXCM - Benzinga
How to escape a deep drawdown in DexCom Inc.Quarterly Profit Report & AI Powered Market Entry Ideas - newser.com
DexCom, Inc. $DXCM Shares Acquired by J. Safra Sarasin Holding AG - MarketBeat
Dexcom Schedules Third Quarter 2025 Earnings Release and Conference Call for October 30, 2025 at 4:30 p.m. Eastern Time. - BioSpace
Dexcom Inc (DXCM) 財務データ
収益
当期純利益
現金流量
EPS
Dexcom Inc (DXCM) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Stern Sadie | EVP, Chief HR Officer |
Sep 04 '25 |
Sale |
80.00 |
1,466 |
117,280 |
105,223 |
2.50%
大文字化:
|
ボリューム (24 時間):